血压控制不平稳?试试这几个办法!

2018-05-13 郭艺芳 郭艺芳心前沿

很多老年人早晨的血压明显升高。这种情况下,早晨清醒后不宜立刻起床,床上缓慢肢体活动一刻钟左右再起床;起床后活动不宜过于剧烈,适当推迟晨练时间;开始晨练前30分钟~1小时服降压药;严重晨峰者应调整锻炼时间至下午或晚上;根据血压节律确定用药时间。

1.老年人严重清晨高血压

很多老年人早晨的血压明显升高。这种情况下,早晨清醒后不宜立刻起床,床上缓慢肢体活动一刻钟左右再起床;起床后活动不宜过于剧烈,适当推迟晨练时间;开始晨练前30分钟~1小时服降压药;严重晨峰者应调整锻炼时间至下午或晚上;根据血压节律确定用药时间。若夜间高血压,可选择睡前服用长效降压药。

2.老年人体位性低血压

一些老年人由卧位或坐位站起来时感觉头晕眼黑,这可能是体位性低血压。遇到这种情况,应停用可能的药物(硝酸酯、三环类抗抑郁药、神经松弛剂和ɑ阻滞剂等);血容量减少者适量增加盐与液体摄入;防止静脉淤血;穿紧身裤和弹力袜;睡眠时头位稍高;坚持体育运动;由卧位转为坐位或立位时动作要缓慢,让身体逐渐适应;基础血压不是很高的患者可考虑减量服用降压药;严重体位性低血压者可短期试用氟氢可的松、米多君、吲哚美辛等。

3.餐后低血压

若饭后出现头晕乏力困倦等低血压症状,要注意是否存在餐后低血压。对于这样的患者,首先要治疗基础疾病(高血压、糖尿病、帕金森病、瘫痪和肾病等);高血压患者可改在两餐之间服降压药;低碳水化合物饮食;少食多餐,避免食物过热;适当增加钠盐和水分摄入;限酒或戒酒;餐后休息10~20分钟后再起立活动,起立前活动四肢;肥胖或糖尿病人可试用阿卡波糖;严重病例可试用米多君。

4.顽固性高血压

除外继发性高血压,诊室高血压,假性高血压,确认患者坚持治疗;.强化生活方式干预,特别是限盐、限酒、减轻体重、缓解紧张焦虑情绪;.至少3种作用机制不同药物联合;冠心病或心衰患者可首选b阻滞剂ACEI/ARB与CCB等药物的联合方式;若无冠心病或慢性心衰,可优选ACEI/ARB+CCB+利尿剂;常规剂量不达标且患者能耐受时,各种药物可用至说明说推荐的最大剂量;利尿剂与螺内酯或是制胜法宝,应积极应用;尝试加BB或a阻滞剂。(一定不要忘记螺内酯!!!)

5.减轻体重的好处

体重下降10公斤:收缩压降低10-20mmHg,胆固醇降低10-20%,血糖降低1-2mmol,心脏负荷降低20%。由此换来的好处是10年内心血管风险下降35%!轻度的高血压、糖尿病、高血脂通过减重就可以达到治疗目的。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=315860, encodeId=7f39315860a9, content=好文章.学习了有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Thu May 17 06:49:40 CST 2018, time=2018-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315632, encodeId=4bda31563252, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Wed May 16 10:06:56 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446301, encodeId=17be1446301a4, content=<a href='/topic/show?id=875e88946d1' target=_blank style='color:#2F92EE;'>#血压控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88946, encryptionId=875e88946d1, topicName=血压控制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28a45200046, createdName=gj0733, createdTime=Tue May 15 13:26:00 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315007, encodeId=97fa31500ec9, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Mon May 14 09:57:07 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314930, encodeId=33ba3149300d, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Mon May 14 06:55:26 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314929, encodeId=4b133149291c, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Mon May 14 06:55:19 CST 2018, time=2018-05-14, status=1, ipAttribution=)]
    2018-05-17 明崖

    好文章.学习了有用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=315860, encodeId=7f39315860a9, content=好文章.学习了有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Thu May 17 06:49:40 CST 2018, time=2018-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315632, encodeId=4bda31563252, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Wed May 16 10:06:56 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446301, encodeId=17be1446301a4, content=<a href='/topic/show?id=875e88946d1' target=_blank style='color:#2F92EE;'>#血压控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88946, encryptionId=875e88946d1, topicName=血压控制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28a45200046, createdName=gj0733, createdTime=Tue May 15 13:26:00 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315007, encodeId=97fa31500ec9, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Mon May 14 09:57:07 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314930, encodeId=33ba3149300d, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Mon May 14 06:55:26 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314929, encodeId=4b133149291c, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Mon May 14 06:55:19 CST 2018, time=2018-05-14, status=1, ipAttribution=)]
    2018-05-16 186****0580(小山羊)

    学习了谢谢了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=315860, encodeId=7f39315860a9, content=好文章.学习了有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Thu May 17 06:49:40 CST 2018, time=2018-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315632, encodeId=4bda31563252, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Wed May 16 10:06:56 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446301, encodeId=17be1446301a4, content=<a href='/topic/show?id=875e88946d1' target=_blank style='color:#2F92EE;'>#血压控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88946, encryptionId=875e88946d1, topicName=血压控制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28a45200046, createdName=gj0733, createdTime=Tue May 15 13:26:00 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315007, encodeId=97fa31500ec9, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Mon May 14 09:57:07 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314930, encodeId=33ba3149300d, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Mon May 14 06:55:26 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314929, encodeId=4b133149291c, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Mon May 14 06:55:19 CST 2018, time=2018-05-14, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=315860, encodeId=7f39315860a9, content=好文章.学习了有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Thu May 17 06:49:40 CST 2018, time=2018-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315632, encodeId=4bda31563252, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Wed May 16 10:06:56 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446301, encodeId=17be1446301a4, content=<a href='/topic/show?id=875e88946d1' target=_blank style='color:#2F92EE;'>#血压控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88946, encryptionId=875e88946d1, topicName=血压控制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28a45200046, createdName=gj0733, createdTime=Tue May 15 13:26:00 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315007, encodeId=97fa31500ec9, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Mon May 14 09:57:07 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314930, encodeId=33ba3149300d, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Mon May 14 06:55:26 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314929, encodeId=4b133149291c, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Mon May 14 06:55:19 CST 2018, time=2018-05-14, status=1, ipAttribution=)]
    2018-05-14 186****0580(小山羊)

    学习了谢谢了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=315860, encodeId=7f39315860a9, content=好文章.学习了有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Thu May 17 06:49:40 CST 2018, time=2018-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315632, encodeId=4bda31563252, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Wed May 16 10:06:56 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446301, encodeId=17be1446301a4, content=<a href='/topic/show?id=875e88946d1' target=_blank style='color:#2F92EE;'>#血压控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88946, encryptionId=875e88946d1, topicName=血压控制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28a45200046, createdName=gj0733, createdTime=Tue May 15 13:26:00 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315007, encodeId=97fa31500ec9, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Mon May 14 09:57:07 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314930, encodeId=33ba3149300d, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Mon May 14 06:55:26 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314929, encodeId=4b133149291c, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Mon May 14 06:55:19 CST 2018, time=2018-05-14, status=1, ipAttribution=)]
    2018-05-14 张新亮1853311252142e2fm

    好文献.学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=315860, encodeId=7f39315860a9, content=好文章.学习了有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Thu May 17 06:49:40 CST 2018, time=2018-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315632, encodeId=4bda31563252, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Wed May 16 10:06:56 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446301, encodeId=17be1446301a4, content=<a href='/topic/show?id=875e88946d1' target=_blank style='color:#2F92EE;'>#血压控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88946, encryptionId=875e88946d1, topicName=血压控制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28a45200046, createdName=gj0733, createdTime=Tue May 15 13:26:00 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315007, encodeId=97fa31500ec9, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Mon May 14 09:57:07 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314930, encodeId=33ba3149300d, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Mon May 14 06:55:26 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314929, encodeId=4b133149291c, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Mon May 14 06:55:19 CST 2018, time=2018-05-14, status=1, ipAttribution=)]
    2018-05-14 张新亮1853311252142e2fm

    好文献.学习了

    0

相关资讯

JAMA Neurol:血压控制与老年认知障碍

对于70岁以下需进行降压治疗的人群,收缩压控制在120mmHg以下可显著降低患者的认知功能障碍风险,该结果对于黑人人群尤为显著

Ann Intern Med:多维度干预可实现更佳BP控制

一项比较效果分析结果显示,高血压患者的血压(BP)控制最好是通过多水平、多组分干预策略来实现,其中包括医生和非医生主导的干预措施。该项研究在线发表于2017年12月26日的Annals of Internal Medicine。

顽固性高血压的诊断与治疗——解析2017年美国高血压指南

在我国、特别是北方地区,居民食盐摄入量普遍较高,因此摄盐过多也是导致顽固性高血压的重要原因之一。与血压较易达标的患者相比,顽固性高血压患者发生心肌梗死、卒中与死亡的风险增高20-60%。因此,加强对顽固性高血压的综合管理,是提高高血压防治水平的关键环节。

Hypertension:CKD儿童血压控制是否有所改善

对于慢性肾脏疾病(CKD)患者,高血压未控制是导致CKD进展和心血管疾病风险增加的主要因素之一。Hypertension发表的一项最新研究对儿童慢性肾脏疾病(CKiD)研究中两个时间段的血压控制情况进行对比分析。

NEW ENGL J MED:强化血压控制对长期健康和生活质量有益

两项研究进一步证实,使收缩压降低到120mmHg(远低于标准指南140mmHg)这个比较激进的值,能够降低高血压患者罹患心脏病的风险。新研究表明,强化血压控制受到患者的良好耐受,并且在健康相关的生活质量和医疗保健系统的财务成本方面具有成本效益。

Lancet:中国高血压的流行、疾病意识、治疗以及控制情况研究

研究发现,中国35-75岁人群,高血压比例接近50%,但治疗率仅30%,高血压控制率小于10%。中国高血压的预防与治疗形式十分严峻